SpectraCure

SpectraCure, based in Lund, Sweden, is a medical device company. SpectraCure is a medical technology company developing a photodynamic therapy (PDT) treatment system for localised prostate cancer, with potential future applications in breast, pancreatic and head/neck cancer. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in prostate cancer. The largest, NCT03067051 (Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System), plans to enrol 66 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.